PB1804: CLINICAL AND DEMOGRAFIC RELATIONS OF BAALC GENE OVEREXPRESSION IN AML PATIENTS - A SINGLE-CENTER OBSERVATIONS

por Aleksov, E., Jagurinoski, M., Tonev, I., Venkov, K., Genova, M., Balatzenko, G., Lazarova, Y., Arnaudov, G., Spasov, B.
Publicado 2022

PB1823: SECONDARY ACUTE MYELOID LEUKEMIA AND DE NOVO ACUTE MYELOID LEUKEMIA WITH MYELODYSPLASIA-RELATED CHANGES DISTINCT LANDSCAPE, OR THE SAME DISEASE?

por Jagurinoski, M., Aleksov, E., Stojcov-Jagurinoska, M., Tonev, I., Vladimirova, R., Davidkova, Y., Balatzenko, G., Spassov, B., Guenova, M.
Publicado 2022

PB2195: MOBILIZATION WITH CYTARABINE AND GRANULOCYTE COLONY STIMULATING FACTOR (G-CSF) GIVES BETTER YIELD THAN MOBILIZATION WITH G-CSF ALONE OR COMBINED WITH CYCLOPHOSPHAMIDE

por Simeonov, S., Tonev, I., Denchev, V., Stoichov, M., Davidkova, Y., Aleksov, E., Zhivkov, T., Stoyanova, M., Donchev, M., Arnaudov, G., Mincheff, M.
Publicado 2022

P1626: MANAGEMENT OF POST-TRANSFUSION COMPLICATIONS IN PATIENTS WITH HEMATOLOGICAL DISEASES. PREVENTION IS BETTER THAN CURE–DATA FROM A SINGLE INSTITUTION

por Lazarova, Y., Balatzenko, G., Aleksov, E., Stoyanova, M., Venkov, K., Milcheva, K., Arnaudov, G., Donchev, M., Ignatova, K., Spassov, B.
Publicado 2022